1. Home
  2. LCID vs SGP Comparison

LCID vs SGP Comparison

Compare LCID & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lucid Group Inc.

LCID

Lucid Group Inc.

N/A

Current Price

$2.97

Market Cap

1.5B

ML Signal

N/A

Logo SpyGlass Pharma Inc. Common Stock

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$33.04

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LCID
SGP
Founded
2007
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
LCID
SGP
Price
$2.97
$33.04
Analyst Decision
Hold
Strong Buy
Analyst Count
11
6
Target Price
$6.06
★ $46.33
AVG Volume (30 Days)
★ 11.9M
99.4K
Earning Date
11-09-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $595,271,000.00
N/A
Revenue This Year
$11.08
N/A
Revenue Next Year
$112.41
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.37
$17.06
52 Week High
$14.26
$39.92

Technical Indicators

Market Signals
Indicator
LCID
SGP
Relative Strength Index (RSI) 38.95 55.62
Support Level $2.87 $25.28
Resistance Level $3.61 N/A
Average True Range (ATR) 0.32 2.38
MACD 0.04 -0.06
Stochastic Oscillator 5.34 34.54

Price Performance

Historical Comparison
LCID
SGP

About LCID Lucid Group Inc.

Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design, which led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: